Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 362

1.

Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.

Bunch TJ, Hohnloser SH, Gersh BJ.

Circulation. 2007 May 8;115(18):2451-7. Review. No abstract available.

2.

Implantable cardioverter-defibrillator therapy and the total burden of sudden cardiac death.

Huikuri HV.

Europace. 2009 Dec;11(12):1574. doi: 10.1093/europace/eup366. No abstract available.

3.

Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death.

Das MK, Gaitonde R, Miller JM.

Curr Cardiol Rep. 2007 Sep;9(5):371-80. Review.

PMID:
17877932
4.

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.

Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.

Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155.

5.

Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.

Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators..

N Engl J Med. 2005 Jun 23;352(25):2581-8. Erratum in: N Engl J Med. 2005 Aug 18;353(7):744.

6.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

PMID:
19752408
7.

New indications for implantable defibrillator therapy.

Poole JE; Centers for Medicare and Medicaid Services (CMS) reimbursement guildlines..

Curr Cardiol Rep. 2006 Sep;8(5):330-5. Review.

PMID:
16956447
8.

The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias.

Green MS, Ricci J, Wolfe K.

Can J Cardiol. 2000 Jun;16 Suppl C:13C-5C. Review. No abstract available.

PMID:
10887271
9.

Life versus death.

Moss AJ.

Circulation. 2008 Apr 15;117(15):1912-3. doi: 10.1161/CIRCULATIONAHA.108.770156. No abstract available.

10.

Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.

Kuch M, Janiszewski M, Mamcarz A, Cudnoch-Jedrzejewska A, Dłuzniewski M.

Med Sci Monit. 2009 Jun;15(6):PH40-8.

PMID:
19478711
11.

[Arrhythmia risk stratification based on etiological and anatomo-structural factors].

Disertori M, Dallafior D, Marini M.

Ital Heart J Suppl. 2001 Dec;2(12):1265-9. Review. Italian.

PMID:
11838346
12.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

13.

Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.

Goldberger JJ, Passman R.

J Am Coll Cardiol. 2009 Nov 24;54(22):2001-5. doi: 10.1016/j.jacc.2009.08.018.

14.

Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT.

Barsheshet A, Goldenberg I, Narins CR, Moss AJ, McNitt S, Wang PJ, Huang DT, Hall WJ, Zareba W, Eldar M, Guetta V.

Heart Rhythm. 2010 Oct;7(10):1421-7. doi: 10.1016/j.hrthm.2010.07.005.

PMID:
20620231
15.

Ethical issues with implantable defibrillators.

Veenhuyzen GD, Simpson CS.

Pacing Clin Electrophysiol. 2005 Feb;28(2):173-4; author reply 174. No abstract available.

PMID:
15679652
16.

Ethical issues with implantable defibrillators.

Brennan FJ.

Pacing Clin Electrophysiol. 2004 Jul;27(7):897-8. No abstract available.

PMID:
15271005
17.

Relation between time from myocardial infarction to enrolment and patient outcomes in the Multicenter UnSustained Tachycardia Trial.

Al-Khatib SM, Hafley G, Lee KL, Buxton AE.

Europace. 2010 Aug;12(8):1112-8. doi: 10.1093/europace/euq116.

18.

Implantable cardioverter-defibrillators after myocardial infarction.

Myerburg RJ.

N Engl J Med. 2008 Nov 20;359(21):2245-53. doi: 10.1056/NEJMra0803409. Review. No abstract available.

PMID:
19020326
19.
20.

[Limitations and possibilities of noninvasive risk stratification for sudden cardiac death].

Tönnis T, Kuck KH.

Herz. 2009 Nov;34(7):506-16. doi: 10.1007/s00059-009-3290-x. Review. German.

PMID:
20091250
Items per page

Supplemental Content

Support Center